by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | Nov 4, 2016 | Advocacy, Government
Last month it was widely reported that big pharmaceutical companies were kicking in a fresh $300 million for myriad government, media, and “advocacy” efforts to keep drug prices high. The Pharmaceutical Researchers and Manufacturers of America, also known as Big Pharma, has asked its members, such as Eli Lilly, Merck and Pfizer to kick in $100 million more this next year because they know we’re on offense and they’re on defense. Part of their efforts will almost certainly include continuing to chip away at your ability to buy lower cost medication from other countries.
But you can fight back by donating to RxRights. For almost six years, RxRights has advocated on behalf of American consumers who import medication for personal use, many who do so through online pharmacies. Through advocacy, education and rallying Americans, RxRights is a bright light in our movement to end the stranglehold that big pharma has on our government!
RxRights is dependent on real people, everyday Americans who care about their families and friends who can’t afford medications. I know, many of you are looking for prescription savings already and it’s hard to part with your money. For those of you who are seriously cash strapped and struggling to afford your meds, keep your money and make sure you have the treatments you need to stay healthy. But like other Americans, if you’ve benefited financially from lower drug prices in other countries and have some bucks to spare then GIVE! You’ll be protecting your own financial interests and doing the right thing for others who absolutely need the lower prices or won’t get the medications they need to live health lives.
Tagged with: donate, RxRights
by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | Oct 6, 2016 | Advocacy
If you would like the presidential debate this Sunday to cover the topic of personal drug importation, then vote here. It’s already known that both Clinton and Trump support expressly legalizing personal drug importation – but it would be better to hear them talk about it before tens of millions of people!
The Campaign for Personal Prescription Importation, PharmacyChecker.com, RxRights, Prescription Justice, and TodaysSeniorsNetwork came together in a joint effort to nudge the candidates to address the issue of importation during the debate. Our coalition is asking Americans to vote to include the following question in the debate: “What would you do to ensure access to affordable medications through importation?” We are also encouraging consumers to pipe up on social media and get their stories out there to Anderson Cooper and Martha Raddatz, the debate’s moderators.
For more information on this advocacy effort, see the news release.
Tagged with: anderson cooper, clinton, cppi, debate, prescription justice, RxRights, trump
by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | Sep 1, 2016 | Advocacy, Government, Personal Drug Importation, Politics
Want Lower Cost Medication
One week ago, the CEO and founder of PharmacyChecker.com, Tod Cooperman, and RxRights leader Lee Graczyk, published an op-ed in The Hill’s Congress Blog, entitled: “The candidates agree: Legalize personal imports of prescription drugs.” In a nutshell, as the title makes clear, Hillary Clinton and Donald Trump both support making it expressly legal to import prescription medication for personal use. This issue is sometimes one of life and death as the media spotlight on Mylan’s drug price spike of Epipen last week makes clear. You might be thinking, “Well, no one gets busted for importing personal prescription orders now so what’s the big deal?” It’s a huge deal.
Currently, about four million Americans import medication for personal use due to cost. But there are more Americans who need to in order to get the medications prescribed to them. If it were technically legal, millions more Americans would buy lower cost medication from Canada and other countries. How many? (more…)
Tagged with: clinton, cooperman, graczyk, RxRights, the hill, trump
Last month it was widely reported that big pharmaceutical companies were kicking in a fresh $300 million for myriad government, media, and “advocacy” efforts to keep drug prices high. The Pharmaceutical Researchers and Manufacturers of America, also known as Big Pharma, has asked its members, such as Eli Lilly, Merck and Pfizer to kick in $100 million more this next year because they know we’re on offense and they’re on defense. Part of their efforts will almost certainly include continuing to chip away at your ability to buy lower cost medication from other countries.
